Veterinary Medicines

Endex 19.5 % w/v Oral Suspension for Cattle

Not authorised
  • Levamisole hydrochloride
  • Triclabendazole
Download as PDF

Product identification

Medicine name:
Endex 19.5 % w/v Oral Suspension for Cattle
Active substance:
  • Levamisole hydrochloride
  • Triclabendazole
Target species:
  • Cattle
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Levamisole hydrochloride
    7.50
    gram(s)
    /
    100.00
    millilitre(s)
  • Triclabendazole
    12.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        46
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC30
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Ireland
Package description:
  • 12 litre HDPE containers with screw cap lids containing white to off-white aqueous suspension.
  • 2.2 litre HDPE containers with screw cap lids containing white to off-white aqueous suspension.
  • 0.8 litre HDPE containers with screw cap lids containing white to off-white aqueous suspension.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S.
  • Argenta Dundee Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22020/035/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download